RAS question
Which Indian organization developed the COVID-19 testing kit 'FELUDA'?
Correct answer: (D) CSIR-IGIB (Institute of Genomics and Integrative Biology).
The COVID-19 testing kit FELUDA was developed by CSIR-IGIB, the Institute of Genomics and Integrative Biology.
Explanation
FELUDA stands for FNCAS9 Editor-Linked Uniform Detection Assay, and the PIB release identifies it as a COVID-19 diagnostic technology from CSIR's constituent lab, the Institute of Genomics and Integrative Biology (CSIR-IGIB). CSIR-IGIB and Tata Sons signed an MoU to license the know-how so it could be scaled into a testing kit. The test uses CRISPR technology to detect the genomic sequence of the novel coronavirus, with a simple protocol and visible paper-strip readout. That is why CSIR-IGIB, not a hospital or a coordinating body, is the developer named for FELUDA. The PIB release also highlights its practical value: affordability, relative ease of use, and no dependence on expensive Q-PCR machines.
Why the other options are wrong
- (A) DRDO is associated with the DIPCOVAN antibody detection kit, whereas FELUDA is a CRISPR-based test developed by CSIR-IGIB.
- (B) AIIMS is a medical institute, whereas CSIR-IGIB is the CSIR constituent laboratory behind the FELUDA know-how.
- (C) ICMR coordinated COVID-19 testing efforts, but FELUDA's development and licensing know-how belonged to CSIR-IGIB.
Concept
Indigenous science-and-technology initiatives in health diagnostics are a recurring RAS theme because institutions are often linked with applied innovations. FELUDA also fits the broader biotechnology area through its use of CRISPR for COVID-19 detection.